NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001772

Registered date:13/03/2009

The clinical study on immunotherapy for advanced renal cell carcinoma =Combination therapy of natural IFN-alfa and meloxicam against metastatic renal cell crcinoma=

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedmetastatic renal cell carcinoma
Date of first enrollment2004/07/01
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)the subcutaneous injection of natural IFN-alfa at 3 mllion unit (MU) or 5 MU three times weekly plus oral administration of meloxicam (Morbic) at 10 mg once daily

Outcome(s)

Primary Outcomeresponse rate
Secondary Outcometime to progression overall survival adverse events

Key inclusion & exclusion criteria

Age minimum15years-old
Age maximum85years-old
GenderMale and Female
Include criteria
Exclude criteria1. prior immunotherapy 2. Brain metastasis 3. Bone metastasis alone 4. active double cancers 5. Liver cirrhosis 6. uncontolled DM 7. Depression

Related Information

Contact

public contact
Name Nobuo Shinohara
Address North-15, West-7, Kitaku, Sapporo Japan
Telephone 011-706-5965
E-mail nobuo-s@med.hokudai.ac.jp
Affiliation Hokkaido University Graduate School of Medicine Department of renal and genitourinary surgery
scientific contact
Name Katsuya Nonomura
Address North-15, West-7, Kitaku, Sapporo Japan
Telephone 011-706-5966
E-mail
Affiliation Hokkaido University Graduate School of Medicine Department of renal and genitourinary surgery